FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288447584> ?p ?o ?g. }

• W4288447584 abstract "Background Scarce information exists in relation to the comparison of seroconversion and adverse events following immunization (AEFI) with different SARS-CoV-2 vaccines. Our aim was to correlate the magnitude of the antibody response to vaccination with previous clinical conditions and AEFI. Methods A multicentric comparative study where SARS-CoV-2 spike 1-2 IgG antibodies IgG titers were measured at baseline, 21-28 days after the first and second dose (when applicable) of the following vaccines: BNT162b2 mRNA, mRNA-1273, Gam-COVID-Vac, Coronavac, ChAdOx1-S, Ad5-nCoV and Ad26.COV2. Mixed model and Poisson generalized linear models were performed. Results We recruited 1867 individuals [52 (SD 16.8) years old, 52% men]. All vaccines enhanced anti-S1 and anti-S2 IgG antibodies over time (p&lt;0.01). The highest increase after the first and second dose was observed in mRNA-1273 (p&lt;0.001). There was an effect of previous SARS-CoV-2 infection; and an interaction of age with previous SARS-CoV-2 infection, Gam-COVID-Vac and ChAdOx1-S (p&lt;0.01). There was a negative correlation of Severe or Systemic AEFI (AEs) of naïve SARS-CoV-2 subjects with age and sex (p&lt;0.001); a positive interaction between the delta of antibodies with Gam-COVID-Vac (p=0.002). Coronavac, Gam-COVID-Vac and ChAdOx1-S had less AEs compared to BNT162b (p&lt;0.01). mRNA-1273 had the highest number of AEFIs. The delta of the antibodies showed an association with AEFIs in previously infected individuals (p&lt;0.001). Conclusions The magnitude of seroconversion is predicted by age, vaccine type and SARS-CoV-2 exposure. AEs are correlated with age, sex, and vaccine type. The delta of the antibody response only correlates with AEs in patients previously exposed to SARS-CoV-2. Registration number ClinicalTrials.gov , identifier NCT05228912." @default.
• W4288447584 created "2022-07-29" @default.
• W4288447584 creator A5004379596 @default.
• W4288447584 creator A5009360125 @default.
• W4288447584 creator A5010316216 @default.
• W4288447584 creator A5012140252 @default.
• W4288447584 creator A5018829971 @default.
• W4288447584 creator A5019116332 @default.
• W4288447584 creator A5024333381 @default.
• W4288447584 creator A5026628435 @default.
• W4288447584 creator A5029441169 @default.
• W4288447584 creator A5030899687 @default.
• W4288447584 creator A5039504745 @default.
• W4288447584 creator A5043539164 @default.
• W4288447584 creator A5044700771 @default.
• W4288447584 creator A5049432759 @default.
• W4288447584 creator A5049939057 @default.
• W4288447584 creator A5053611002 @default.
• W4288447584 creator A5074729558 @default.
• W4288447584 creator A5076032568 @default.
• W4288447584 creator A5079403434 @default.
• W4288447584 creator A5084507756 @default.
• W4288447584 creator A5085944050 @default.
• W4288447584 creator A5091027502 @default.
• W4288447584 date "2022-07-28" @default.
• W4288447584 modified "2023-10-18" @default.
• W4288447584 title "Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries" @default.
• W4288447584 cites W2059796825 @default.
• W4288447584 cites W3009279917 @default.
• W4288447584 cites W3023330307 @default.
• W4288447584 cites W3036543467 @default.
• W4288447584 cites W3042383115 @default.
• W4288447584 cites W3082342835 @default.
• W4288447584 cites W3111255098 @default.
• W4288447584 cites W3111459703 @default.
• W4288447584 cites W3127329393 @default.
• W4288447584 cites W3127400850 @default.
• W4288447584 cites W3127450935 @default.
• W4288447584 cites W3129250309 @default.
• W4288447584 cites W3134757598 @default.
• W4288447584 cites W3135210768 @default.
• W4288447584 cites W3153508314 @default.
• W4288447584 cites W3159733845 @default.
• W4288447584 cites W3160932186 @default.
• W4288447584 cites W3165181036 @default.
• W4288447584 cites W3169658792 @default.
• W4288447584 cites W3178778712 @default.
• W4288447584 cites W3197512904 @default.
• W4288447584 cites W3199602254 @default.
• W4288447584 cites W3201445897 @default.
• W4288447584 cites W3202950023 @default.
• W4288447584 cites W3209290058 @default.
• W4288447584 cites W3216090339 @default.
• W4288447584 cites W3216623344 @default.
• W4288447584 cites W4200001594 @default.
• W4288447584 cites W4200135346 @default.
• W4288447584 cites W4200454749 @default.
• W4288447584 cites W4200629697 @default.
• W4288447584 cites W4205393500 @default.
• W4288447584 cites W4205483821 @default.
• W4288447584 cites W4205884115 @default.
• W4288447584 cites W4205896335 @default.
• W4288447584 cites W4225711802 @default.
• W4288447584 cites W4229035098 @default.
• W4288447584 doi "https://doi.org/10.3389/fimmu.2022.894277" @default.
• W4288447584 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35967368" @default.
• W4288447584 hasPublicationYear "2022" @default.
• W4288447584 type Work @default.
• W4288447584 citedByCount "8" @default.
• W4288447584 countsByYear W42884475842022 @default.
• W4288447584 countsByYear W42884475842023 @default.
• W4288447584 crossrefType "journal-article" @default.
• W4288447584 hasAuthorship W4288447584A5004379596 @default.
• W4288447584 hasAuthorship W4288447584A5009360125 @default.
• W4288447584 hasAuthorship W4288447584A5010316216 @default.
• W4288447584 hasAuthorship W4288447584A5012140252 @default.
• W4288447584 hasAuthorship W4288447584A5018829971 @default.
• W4288447584 hasAuthorship W4288447584A5019116332 @default.
• W4288447584 hasAuthorship W4288447584A5024333381 @default.
• W4288447584 hasAuthorship W4288447584A5026628435 @default.
• W4288447584 hasAuthorship W4288447584A5029441169 @default.
• W4288447584 hasAuthorship W4288447584A5030899687 @default.
• W4288447584 hasAuthorship W4288447584A5039504745 @default.
• W4288447584 hasAuthorship W4288447584A5043539164 @default.
• W4288447584 hasAuthorship W4288447584A5044700771 @default.
• W4288447584 hasAuthorship W4288447584A5049432759 @default.
• W4288447584 hasAuthorship W4288447584A5049939057 @default.
• W4288447584 hasAuthorship W4288447584A5053611002 @default.
• W4288447584 hasAuthorship W4288447584A5074729558 @default.
• W4288447584 hasAuthorship W4288447584A5076032568 @default.
• W4288447584 hasAuthorship W4288447584A5079403434 @default.
• W4288447584 hasAuthorship W4288447584A5084507756 @default.
• W4288447584 hasAuthorship W4288447584A5085944050 @default.
• W4288447584 hasAuthorship W4288447584A5091027502 @default.
• W4288447584 hasBestOaLocation W42884475841 @default.
• W4288447584 hasConcept C113280763 @default.
• W4288447584 hasConcept C126322002 @default.
• W4288447584 hasConcept C159654299 @default.
• W4288447584 hasConcept C197934379 @default.
• W4288447584 hasConcept C203014093 @default.

• next